Patients with inflammatory bowel disease (IBD) commonly have symptoms of diarrhea and abdominal pain. These symptoms can be related to ongoing inflammation, or alternatively, to an overlap of IBD and irritable bowel syndrome (IBD-IBS). Limited data are available on how IBS impacts the individual IBD patient's care and functional status. In this study we aimed to evaluate the prevalence of IBD-IBS within the CCFA Partners cohort and investigate the impact of this diagnosis on various patient-reported outcomes, including measures of functional status, and specific medication utilization such as narcotic use.
